Cargando…
Nonmelanoma Skin Cancer at Critical Facial Sites: Results and Strategies of the Surgical Treatment of 102 Patients
BACKGROUND: To evaluate the surgical treatment results of a consecutive series of patients with nonmelanoma skin cancer in critical facial regions such as the nose, lip, eyelid, ear, forehead, cheek, and chin. METHODS: This was a prospective observational cohort study evaluating the surgical treatme...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617868/ https://www.ncbi.nlm.nih.gov/pubmed/31346477 http://dx.doi.org/10.1155/2019/4798510 |
_version_ | 1783433790024056832 |
---|---|
author | de Freitas, Carlos Alberto Ferreira Santos, Andreza Negreli Bittner, Guilherme Canho Sanabria, Baltazar Dias Levenhagen, Maria Margarida Morena Domingos Hans-Filho, Günther |
author_facet | de Freitas, Carlos Alberto Ferreira Santos, Andreza Negreli Bittner, Guilherme Canho Sanabria, Baltazar Dias Levenhagen, Maria Margarida Morena Domingos Hans-Filho, Günther |
author_sort | de Freitas, Carlos Alberto Ferreira |
collection | PubMed |
description | BACKGROUND: To evaluate the surgical treatment results of a consecutive series of patients with nonmelanoma skin cancer in critical facial regions such as the nose, lip, eyelid, ear, forehead, cheek, and chin. METHODS: This was a prospective observational cohort study evaluating the surgical treatment results of 102 patients with nonmelanoma skin cancer who underwent surgical excision and required some type of reconstruction. The reconstruction strategy used, histological type and margins, aesthetic result, and complications were evaluated. RESULTS: The most common facial site was the nose (48.01%), followed by the eyelid, ear, cheek, forehead, and lip. The most frequently used type of reconstruction was the advancement flap (30.39%), followed by transposition flap (27,45%), rotation flap (14.70%), and grafts (10.78%). Basal cell carcinoma was the most frequent histological type, accounting for 90.19% of the sample, with 54.90% of these cases being of the nodular subtype. Disease-free margins were obtained in 94.11% of the patients, and only one patient presented compromised margins and underwent marginal extension. A good cosmetic result was found in 93.13% of the participants. CONCLUSION: Surgical treatment can provide excellent oncological, functional, and cosmetic results in the treatment of patients with nonmelanoma skin cancer at critical facial sites. |
format | Online Article Text |
id | pubmed-6617868 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-66178682019-07-25 Nonmelanoma Skin Cancer at Critical Facial Sites: Results and Strategies of the Surgical Treatment of 102 Patients de Freitas, Carlos Alberto Ferreira Santos, Andreza Negreli Bittner, Guilherme Canho Sanabria, Baltazar Dias Levenhagen, Maria Margarida Morena Domingos Hans-Filho, Günther J Skin Cancer Clinical Study BACKGROUND: To evaluate the surgical treatment results of a consecutive series of patients with nonmelanoma skin cancer in critical facial regions such as the nose, lip, eyelid, ear, forehead, cheek, and chin. METHODS: This was a prospective observational cohort study evaluating the surgical treatment results of 102 patients with nonmelanoma skin cancer who underwent surgical excision and required some type of reconstruction. The reconstruction strategy used, histological type and margins, aesthetic result, and complications were evaluated. RESULTS: The most common facial site was the nose (48.01%), followed by the eyelid, ear, cheek, forehead, and lip. The most frequently used type of reconstruction was the advancement flap (30.39%), followed by transposition flap (27,45%), rotation flap (14.70%), and grafts (10.78%). Basal cell carcinoma was the most frequent histological type, accounting for 90.19% of the sample, with 54.90% of these cases being of the nodular subtype. Disease-free margins were obtained in 94.11% of the patients, and only one patient presented compromised margins and underwent marginal extension. A good cosmetic result was found in 93.13% of the participants. CONCLUSION: Surgical treatment can provide excellent oncological, functional, and cosmetic results in the treatment of patients with nonmelanoma skin cancer at critical facial sites. Hindawi 2019-06-26 /pmc/articles/PMC6617868/ /pubmed/31346477 http://dx.doi.org/10.1155/2019/4798510 Text en Copyright © 2019 Carlos Alberto Ferreira de Freitas et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study de Freitas, Carlos Alberto Ferreira Santos, Andreza Negreli Bittner, Guilherme Canho Sanabria, Baltazar Dias Levenhagen, Maria Margarida Morena Domingos Hans-Filho, Günther Nonmelanoma Skin Cancer at Critical Facial Sites: Results and Strategies of the Surgical Treatment of 102 Patients |
title | Nonmelanoma Skin Cancer at Critical Facial Sites: Results and Strategies of the Surgical Treatment of 102 Patients |
title_full | Nonmelanoma Skin Cancer at Critical Facial Sites: Results and Strategies of the Surgical Treatment of 102 Patients |
title_fullStr | Nonmelanoma Skin Cancer at Critical Facial Sites: Results and Strategies of the Surgical Treatment of 102 Patients |
title_full_unstemmed | Nonmelanoma Skin Cancer at Critical Facial Sites: Results and Strategies of the Surgical Treatment of 102 Patients |
title_short | Nonmelanoma Skin Cancer at Critical Facial Sites: Results and Strategies of the Surgical Treatment of 102 Patients |
title_sort | nonmelanoma skin cancer at critical facial sites: results and strategies of the surgical treatment of 102 patients |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617868/ https://www.ncbi.nlm.nih.gov/pubmed/31346477 http://dx.doi.org/10.1155/2019/4798510 |
work_keys_str_mv | AT defreitascarlosalbertoferreira nonmelanomaskincanceratcriticalfacialsitesresultsandstrategiesofthesurgicaltreatmentof102patients AT santosandrezanegreli nonmelanomaskincanceratcriticalfacialsitesresultsandstrategiesofthesurgicaltreatmentof102patients AT bittnerguilhermecanho nonmelanomaskincanceratcriticalfacialsitesresultsandstrategiesofthesurgicaltreatmentof102patients AT sanabriabaltazardias nonmelanomaskincanceratcriticalfacialsitesresultsandstrategiesofthesurgicaltreatmentof102patients AT levenhagenmariamargaridamorenadomingos nonmelanomaskincanceratcriticalfacialsitesresultsandstrategiesofthesurgicaltreatmentof102patients AT hansfilhogunther nonmelanomaskincanceratcriticalfacialsitesresultsandstrategiesofthesurgicaltreatmentof102patients |